Sclerostin and Its Involvement in the Pathogenesis of Idiopathic Scoliosis
Abstract
:1. Introduction
2. Sclerostin Structure, Expression, and Regulation
3. Osteocytes in Idiopathic Scoliosis
4. Sclerostin and Idiopathic Scoliosis
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
References
- Cheng, J.C.; Tang, N.L.; Yeung, H.Y.; Miller, N. Genetic association of complex traits: Using idiopathic scoliosis as an example. Clin. Orthop. Relat. Res. 2007, 462, 38–44. [Google Scholar] [CrossRef]
- van Bezooijen, R.L.; Roelen, B.A.; Visser, A.; van der Wee-Pals, L.; de Wilt, E.; Karperien, M.; Hamersma, H.; Papapoulos, S.E.; ten Dijke, P.; Löwik, C.W. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J. Exp. Med. 2004, 199, 805–814. [Google Scholar] [CrossRef]
- Hamersma, H.; Gardner, J.; Beighton, P. The natural history of sclerosteosis. Clin. Genet. 2003, 63, 192–197. [Google Scholar] [CrossRef] [PubMed]
- Van Buchem, F.S.P.; Hadders, H.N.; Hansen, J.F.; Woldring, M.G. Hyperostosis Corticalis Generalisata: Report of Seven Cases. Am. J. Med. 1962, 33, 387–397. [Google Scholar] [CrossRef]
- Cheng, J.C.; Guo, X.; Sher, A.H. Persistent osteopenia in adolescent idiopathic scoliosis. A longitudinal follow up study. Spine 1999, 24, 1218–1222. [Google Scholar] [CrossRef] [PubMed]
- Hung, V.W.; Qin, L.; Cheung, C.S.; Lam, T.P.; Ng, B.K.; Tse, Y.K.; Guo, X.; Lee, K.M.; Cheng, J.C. Osteopenia: A new prognostic factor of curve progression in adolescent idiopathic scoliosis. J. Bone Jt. Surg. Am. 2005, 87, 2709–2716. [Google Scholar]
- Wang, Z.; Chen, H.; Yu, Y.E.; Zhang, J.; Cheuk, K.; Ng, B.K.; Qiu, Y.; Guo, X.E.; Cheng, J.C.; Lee, W.Y. Unique local bone tissue characteristics in iliac crest bone biopsy from adolescent idiopathic scoliosis with severe spinal deformity. Sci. Rep. 2017, 7, 40265. [Google Scholar] [CrossRef] [Green Version]
- Tanabe, H.; Aota, Y.; Nakamura, N.; Saito, T. A histomorphometric study of the cancellous spinal process bone in adolescent idiopathic scoliosis. Eur. Spine J. 2017, 26, 1600–1609. [Google Scholar] [CrossRef]
- Zhang, J.; Chen, H.; Leung, R.K.K.; Choy, K.W.; Lam, T.P.; Ng, B.K.W.; Qiu, Y.; Feng, J.Q.; Cheng, J.C.Y.; Lee, W.Y.W. Aberrant miR-145-5p/b-catenin signal impairs osteocyte function in adolescent idiopathic scoliosis. FASEB J. 2018, 32, 6537–6549. [Google Scholar] [CrossRef]
- Balemans, W.; Van Den Ende, J.; Paes-Alves, F.; Dikkers, F.G.; Willems, P.J.; Vanhoenacker, F.; de Almeida-Melo, N.; Alves, C.F.; Stratakis, C.A.; Hill, S.C.; et al. Localization of the gene for sclerosteosis to the van Buchem disease-gene region on chromosome 17q12-q21. Am. J. Hum. Genet. 1999, 64, 1661–1669. [Google Scholar] [CrossRef] [Green Version]
- Van Hul, W.; Balemans, W.; Van Hul, E.; Dikkers, F.G.; Obee, H.; Stokroos, R.J.; Hildering, P.; Vanhoenacker, F.; Van Camp, G.; Willems, P.J. Van Buchem disease (hyperostosis corticalis generalisata) maps to chromosome 17q12-q21. Am. J. Hum. Genet. 1998, 62, 391–399. [Google Scholar] [CrossRef] [Green Version]
- Hernandez, P.; Whitty, C.; Wardale, R.J.; Henson, F.M.D. New insights into the location and form of sclerostin. Biochem. Biophys. Res. Commun. 2014, 446, 1108–1113. [Google Scholar] [CrossRef]
- Brunkow, M.E.; Gardner, J.C.; Van Ness, J.; Paeper, B.W.; Kovacevich, B.R.; Proll, S.; Skonier, J.E.; Zhao, L.; Sabo, P.J.; Fu, Y.; et al. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am. J. Hum. Genet. 2001, 68, 577–589. [Google Scholar] [CrossRef] [Green Version]
- Weidauer, S.E.; Schmieder, P.; Beerbaum, M.; Schmitz, W.; Oschkina, H.; Mueller, T.D. NMR structure of the Wnt modulator protein Sclerostin. Biochem. Biophys. Res. Commun. 2009, 380, 160–165. [Google Scholar] [CrossRef] [PubMed]
- Balemans, W.; Ebeling, M.; Patel, N.; Van Hul, E.; Olson, P.; Dioszegi, M.; Lacza, C.; Wuyts, W.; Van Den Ende, J.; Willems, P.; et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum. Mol. Genet. 2001, 10, 537–543. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Winkler, D.G.; Sutherland, M.K.; Geoghegan, J.C.; Yu, C.; Hayes, T.; Skonier, J.E.; Shpektor, D.; Jonas, M.; Kovacevich, B.R.; Staehling-Hampton, K.; et al. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J. 2003, 22, 6267–6276. [Google Scholar] [CrossRef] [Green Version]
- Weivoda, M.M.; Youssef, S.J.; Oursler, M.J. Sclerostin expression and functions beyond the osteocyte. Bone 2017, 96, 45–50. [Google Scholar] [CrossRef] [Green Version]
- Collette, N.M.; Yee, C.S.; Muruquesh, D.; Sebastian, A.; Taher, L.; Gale, N.W.; Economides, A.N.; Harland, R.M.; Loots, G.G. Sost and its paralog Sostdc1 coordinate digit number in a Gli-3dependent manner. Dev. Biol. 2013, 383, 90–105. [Google Scholar] [CrossRef] [Green Version]
- Van Bezooijen, R.L.; Bronckers, A.L.; Gortzak, R.A.; Hogendoorn, P.C.; Van der Wee-Pals, L.; Balemans, W.; Oostenbroek, H.J.; Van Hul, W.; Hamersma, H.; Dikkers, F.G.; et al. Sclerostin in mineralized matrices and van Buchem disease. J. Dent. Res. 2009, 88, 569–574. [Google Scholar] [CrossRef]
- Kusu, N.; Laurikkala, J.; Imanishishi, M.; Usui, H.; Konischi, M.; Miyake, A.; Thesleftt, I.; Itoh, N. Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist wtih unique ligand specificity. J. Biol. Chem. 2003, 278, 24113–24117. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, X.; Ominsky, M.S.; Niu, Q.T.; Sun, N.; Daughterty, B.; D’Agostin, D.; Kurahara, C.; Gao, Y.; Cao, J.; Gong, J.; et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J. Bone Miner. Res. 2008, 23, 860–869. [Google Scholar] [CrossRef]
- Maeda, K.; Kobayashi, Y.; Koide, M.; Uehara, S.; Okamoto, M.; Ishihara, A.; Kayama, T.; Saito, M.; Marumo, K. The Regulation of Bone Metabolism and Disorders by Wnt Signaling. Int. J. Mol. Sci. 2019, 20, 5525. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Semenov, M.V.; He, X. LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST. J. Biol. Chem. 2006, 281, 38276–38284. [Google Scholar] [CrossRef] [Green Version]
- Van Wesenbeeck, L.; Cleiren, E.; Gram, J.; Beals, R.K.; Benichou, O.; Scopelliti, D.; Key, L.; Renton, T.; Bartels, C.; Gong, Y.Q.; et al. Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am. J. Hum. Genet. 2003, 72, 763–771. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hassler, N.; Roschger, A.; Gamsjaeger, S.; Kramer, I.; Lueger, S.; van Lierop, A.; Roschger, P.; Klaushofer, K.; Paschalis, E.P.; Kneissel, M.; et al. Sclerostin Deficiency Is Linked to Altered Bone Composition. J. Bone Miner. Res. 2014, 29, 2144–2151. [Google Scholar] [CrossRef] [PubMed]
- Wijenayaka, A.R.; Kogawa, M.; Lim, H.P.; Bonewald, L.F.; Findlay, D.M.; Atkins, G.J. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway. PLoS ONE 2011, 6, e25900. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Collette, N.M.; Genetos, D.C.; Economides, A.N.; Xie, L.; Shahnazari, M.; Yao, W.; Lane, N.E.; Harland, R.M.; Loots, G.G. Targeted deletion of Sost distal enhancer increases bone formation and bone mass. Proc. Natl. Acad. Sci. USA 2012, 109, 14092–14097. [Google Scholar] [CrossRef] [Green Version]
- Koide, M.; Kobayashi, Y. Regulatory mechanisms of sclerostin expression during bone remodeling. J. Bone Miner. Metab. 2019, 37, 9–17. [Google Scholar] [CrossRef]
- Komori, T. Regulation of Proliferation, Differentiation and Functions of Osteoblasts by Runx2. Int. J. Mol. Sci. 2019, 20, 1694. [Google Scholar] [CrossRef] [Green Version]
- Delgado-Calle, J.; Sanudo, C.; Bolado, A.; Fernandez, A.F.; Arozamena, J.; Pascual-Carra, M.A.; Rodriguez-Rey, J.C.; Fraga, M.F.; Bonewald, L.; Riancho, J.A. DNA methylation contributes to the regulation of sclerostin expression in human osteocytes. J. Bone Miner. Res. 2012, 27, 926–937. [Google Scholar] [CrossRef]
- Wijenayaka, A.R.; Prideaux, M.; Yang, D.; Morris, H.A.; Findlay, D.M.; Anderson, P.H.; Atkins, G.J. Early response of the human SOST gene to stimulation by 1α,25-dihydroxyvitamin D3. J. Steroid Biochem. Mol. Biol. 2016, 164, 369–373. [Google Scholar] [CrossRef] [PubMed]
- St John, H.C.; Hansen, S.J.; Pike, J.W. Analysis of SOST expression using large minigenes reveals the MEF2C binding site in the evolutionarily conserved region (ECR5) enhancer mediates forskolin, but not 1,25-dihydroxyvitamin D or TGFbeta responsiveness. J. Steroid Biochem. Mol. Biol. 2016, 164, 277–280. [Google Scholar] [CrossRef] [Green Version]
- Sakellariou, G.T.; Iliopoulos, A.; Konsta, M.; Kenanidis, E.; Potoupnis, M.; Tsiridis, E.; Gavana, E.; Sayegh, F.E. Serum levels of Dkk-1, sclerostin and VEGF in patients with ankylosing spondylitis and their association with smoking, and clinical, inflammatory and radiographic parameters. Jt. Bone Spine 2017, 84, 309–315. [Google Scholar] [CrossRef] [PubMed]
- Suen, P.K.; Zhu, T.Y.; Chow, D.H.; Huang, L.; Zheng, L.Z.; Qin, L. Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength of Intact Bones in Adult Male Rats. Sci. Rep. 2015, 5, 15632. [Google Scholar] [CrossRef] [PubMed]
- Liu, Y.; Rui, Y.; Cheng, T.Y.; Huang, S.; Xu, L.; Meng, F.; Lee, W.Y.; Zhang, T.; Li, N.; Li, C.; et al. Effects of Sclerostin Antibody on the Healing of Femoral Fractures in Ovariectomised Rats. Calcif. Tissue Int. 2016, 98, 263–274. [Google Scholar] [CrossRef] [PubMed]
- Oranger, A.; Brunetti, G.; Colaianni, G.; Tamma, R.; Carbone, C.; Lippo, L.; Mori, G.; Pignataro, P.; Cirulli, N.; Zerlotin, R.; et al. Sclerostin stimulates angiogenesis in human endothelial cells. Bone 2017, 101, 26–36. [Google Scholar] [CrossRef]
- He, X.; Cheng, R.; Benyajati, S.; Ma, J.X. PEDF and its roles in physiological and pathological conditions: Implication in diabetic and hypoxia-induced angiogenic diseases. Clin. Sci. 2015, 128, 805–823. [Google Scholar] [CrossRef] [Green Version]
- Inagaki, Y.; Hookway, E.S.; Kashima, T.G.; Munemoto, M.; Tanaka, Y.; Hassan, A.B.; Oppermann, U.; Athanasou, N.A. Sclerostin expression in bone tumours and tumour-like lesions. Histopathology 2016, 69, 470–478. [Google Scholar] [CrossRef]
- Sevetson, B.; Taylor, S.; Pan, Y. Cbfa1/RUNX2 directs specific expression of the sclerosteosis gene (SOST). J. Biol. Chem. 2004, 279, 13849–13858. [Google Scholar] [CrossRef] [Green Version]
- Techavichit, P.; Gao, Y.; Kurenbekova, L.; Shuck, R.; Donehower, L.A.; Yustein, J.T. Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential. BMC Cancer 2016, 16, 869. [Google Scholar] [CrossRef] [Green Version]
- Baker, E.K.; Taylor, S.; Gupte, A.; Chalk, A.M.; Bhattacharya, S.; Green, A.C.; Martin, T.J.; Strbenac, D.; Robinson, M.D.; Purton, L.E.; et al. Wnt inhibitory factor 1 (WIF1) is a marker of osteoblastic di_erentiation stage and is not silenced by DNA methylation in osteosarcoma. Bone 2015, 73, 223–232. [Google Scholar] [CrossRef]
- Roforth, M.M.; Fujita, K.; McGregor, U.I.; Kirmani, S.; McCready, L.K.; Peterson, J.M.; Drake, M.T.; Monroe, D.G.; Khosla, S. Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans. Bone 2014, 59, 1–6. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mödder, U.I.; Hoey, K.A.; Amin, S.; McCready, L.K.; Achenbach, S.J.; Riggs, B.L.; Melton, L.J.; Khosla, S. Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J. Bone Miner. Res. 2011, 26, 373–379. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Papachristou, D.J.; Papachroni, K.K.; Basdra, E.K.; Papavassiliou, A.G. Signalimg networks and transcription factors regulating mechanotransduction in bone. BioEssays 2009, 31, 794–804. [Google Scholar] [CrossRef] [PubMed]
- Palumbo, C.; Palazzini, S.; Marotti, G. Morphological study of intercellular junctions during osteocyte differentiation. Bone 1990, 11, 401–406. [Google Scholar] [CrossRef]
- Zeng, Y.; Cowin, S.C.; Weinbaum, S. A fiber matrix model for fluid flow and streaming potentials in the canaliculi of an osteon. Ann. Biomed. Eng. 1994, 22, 280–292. [Google Scholar] [CrossRef]
- Genetos, D.C.; Toupadakis, C.A.; Raheja, L.F.; Wong, A.; Papanicolaou, S.E.; Fyhrie, D.P.; Loots, G.G.; Yellowley, C.E. Hypoxia decreases sclerostin expression and increases Wnt signaling in osteoblasts. J. Cell Biochem. 2010, 110, 87–96. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Klein-Nulend, J.; Bakker, A.D.; Bacabac, R.G.; Vatsa, A.; Weinbaum, S. Mechanosensation and transduction in osteocytes. Bone 2013, 54, 182–190. [Google Scholar] [CrossRef] [PubMed]
- Walker, E.C.; McGregor, N.E.; Poulton, I.J.; Solano, M.; Pompolo, S.; Fernandes, T.J.; Constable, M.J.; Nicholson, G.C.; Zhang, J.G.; Nicola, N.A.; et al. Oncostatin M promotes bone formation independently of resorpion when signaling through leukemia inhibitor factor in mice. J. Clin. Investig. 2010, 120, 582–592. [Google Scholar] [CrossRef] [Green Version]
- Cheng, J.C.; Castelein, R.M.; Chu, W.C.; Danielsson, A.J.; Dobbs, M.B.; Grivas, T.B.; Gurnett, C.A.; Luk, K.D.; Moreau, A.; Newton, P.O.; et al. Adolescent idiopathic scoliosis. Nat. Rev. Dis. Primers 2015, 1, 15030. [Google Scholar] [CrossRef] [Green Version]
- Tu, X.; Rhee, Y.; Condon, K.W.; Bivi, N.; Allen, M.R.; Dwyer, D.; Stollina, M.; Turner, C.H.; Robling, A.G.; Plotkin, L.I.; et al. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading. Bone 2012, 50, 209–217. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bonnet, N.; Standley, K.N.; Bianchi, E.N.; Stadelmann, V.; Foti, M.; Conway, S.J.; Ferrari, S.L. The matricellular protein Periostin is required for Sclerostin inhibition and the anabolic response to mechanical loading and physical activity. J. Biol. Chem. 2009, 284, 35939–35950. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hui, S.; Yang, Y.; Li, J.; Li, N.; Xu, P.; Li, H.; Zhang, Y.; Wang, S.; Lin, G.; Li, S.; et al. Differential miRNAs profile and bioinformatics analyses in bone marrow mesenchymal stem cells from adolescent idiopathic scoliosis patients. Spine J. 2019, 19, 1584–1596. [Google Scholar] [CrossRef] [PubMed]
- Suarjana, I.N.; Isbagio, H.; Soewondo, P.; Rachman, I.A.; Sadikin, M.; Prihartono, J.; Malik, S.G.; Soeroso, J. The Role of Serum Expression Levels of Microrna-21 on Bone Mineral Density in Hypostrogenic Postmenopausal Women with Osteoporosis: Study on Level of RANKL, OPG, TGFβ-1, Sclerostin, RANKL/OPG Ratio, and Physical Activity. Acta Med. Indones 2019, 51, 245–252. [Google Scholar] [PubMed]
- Liao, H.; Zhang, Z.; Liu, Z.; Lin, W.; Huang, J.; Huang, Y. Inhibited microRNA-218-5p attenuates synovial inflammation and cartilage injury in rats with knee osteoarthritis by promoting sclerostin. Life Sci. 2021, 267, 118893. [Google Scholar] [CrossRef]
- Hayes, M.; Gao, X.; Yu, L.X.; Paria, N.; Henkelman, R.M.; Wise, C.A.; Ciruna, B. ptk7 mutant zebrafish models of congenital and idiopathic scoliosis implicate dysregulated Wnt signalling in disease. Nat. Commun. 2014, 5, 4777. [Google Scholar] [CrossRef] [Green Version]
- Rodda, S.J.; McMahon, A.P. Distinct roles for hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 2006, 133, 3231–3244. [Google Scholar] [CrossRef] [Green Version]
- Regard, J.B.; Cherman, N.; Palmer, D.; Kuznetsov, S.A.; Celi, F.S.; Guettier, J.M.; Chen, M.; Bhattacharyya, N.; Wess, J.; Coughlin, S.R.; et al. Wnt/b-catenin signaling is differentially regulated by Ga proteins and contributes to fibrous dysplasia. Proc. Natl. Acad. Sci. USA 2011, 108, 20101–20106. [Google Scholar] [CrossRef] [Green Version]
- Cisterna, P.; Henriquez, J.P.; Brandan, E.; Inestrosa, N.C. Wnt signaling in skeletal muscle dynamics: Myogenesis, neuromuscular synapse and fibrosis. Mol. Neurobiol. 2014, 49, 574–589. [Google Scholar] [CrossRef]
- Kondo, N.; Yuasa, T.; Shimono, K.; Tung, W.; Okabe, T.; Yasuhara, R.; Pacifici, M.; Zhang, Y.; Iwamoto, M.; Enomoto-Iwamoto, M. Intervertebral disc development is regulated by Wnt/beta -catenin signaling. Spine 2011, 36, E513–E518. [Google Scholar] [CrossRef] [Green Version]
- Tamamura, Y.; Otani, T.; Kanatani, N.; Koyama, E.; Kitagaki, J.; Komori, T.; Yamada, Y.; Costantini, F.; Wakisaka, S.; Pacifici, M.; et al. Developmental regulation of Wnt/beta-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification. J. Biol. Chem. 2005, 280, 19185–19195. [Google Scholar] [CrossRef] [Green Version]
- Acaroglu, E.; Akel, I.; Alanay, A.; Yazici, M.; Marcucio, R. Comparison of the melatonin and calmodulin in paravertebral muscle and platelets of patients with or without adolescent idiopathic scoliosis. Spine 2009, 34, E659–E663. [Google Scholar] [CrossRef] [PubMed]
- Tansey, M.G.; Luby-Phelps, K.; Kamm, K.E.; Stull, J.T. Ca(2+) dependent phosphorylation of myosin light chain kinase decreases the Ca2+ sensitivity of light chain phosphorylation within smooth muscle cells. J. Biol. Chem. 1994, 269, 9912–9920. [Google Scholar] [CrossRef]
- Nishizawa, Y.; Okui, Y.; Inaba, M.; Okuno, S.; Yukioka, K.; Miki, T.; Watanabe, Y.; Morii, H. Calcium/Cadmodulin-mediated action of calcitonin on lipid metabolism in rats. J. Clin. Investig. 1988, 82, 1165–1172. [Google Scholar] [CrossRef] [PubMed]
- Gooi, J.H.; Pompolo, S.; Karsdal, M.A.; Kulkarni, N.H.; Kalajzic, I.; McAhren, S.H.; Han, B.; Onyia, J.E.; Ho, P.W.; Gillespie, M.T.; et al. Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes. Bone 2010, 46, 1486–1497. [Google Scholar] [CrossRef]
- Zhou, R.; Yuan, Z.; Liu, J.; Liu, J. Calcitonin gene-related peptide promotes the expression of osteoblastic genes and activates the WNT signal transduction pathway in bone marrow stromal stem cells. Mol. Med. Rep. 2016, 13, 4689–4696. [Google Scholar] [CrossRef] [PubMed]
- Xu, E.; Lin, T.; Jiang, H.; Ji, Z.; Shao, W.; Meng, Y.; Gao, R.; Zhou, X. Asymmetric expression of GPR126 in the convex/concave side of the spine is associated with spinal skeletal malformation in adolescent idiopathic scoliosis population. Eur. Spine J. 2019, 28, 1977–1986. [Google Scholar] [CrossRef]
- Murray, D.W.; Bulstrode, C.J. The development of adolescent idiopathic scoliosis. Eur. Spine J. 1996, 5, 251–257. [Google Scholar] [CrossRef] [PubMed]
- Grivas, T.B.; Burwell, G.R.; Vasiliadis, E.S.; Webb, J.K. A segmental radiological study of the spine and rib--cage in children with progressive infantile idiopathic scoliosis. Scoliosis 2016, 1, 17. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Grivas, T.B.; Vasiliadis, E.S.; Polyzois, V.D.; Mouzakis, V. Trunk asymmetry and handedness in 8245 school children. Pediatr. Rehabil. 2006, 9, 259–266. [Google Scholar] [CrossRef] [PubMed]
- Shi, L.; Wang, D.; Chu, W.C.; Burwell, R.G.; Freeman, B.J.; Heng, P.A.; Cheng, J.C. Volume-based morphometry of brain MR images in adolescent idiopathic scoliosis and healthy control subjects. Am. J. Neuroradiol. 2009, 30, 1302–1307. [Google Scholar] [CrossRef]
- Chau, W.W.; Chu, W.C.; Lam, T.P.; Ng, B.K.; Fu, L.L.; Cheng, J.C. Anatomical Origin of Abnormal Somatosensory-Evoked Potential (SEP) in Adolescent Idiopathic Scoliosis with Different Curve Severity and Correlation With Cerebellar Tonsillar Level Determined by MRI. Spine 2016, 41, E598–E604. [Google Scholar] [CrossRef] [Green Version]
- Byl, N.N.; Holland, S.; Jurek, A.; Hu, S.S. Postural imbalance and vibratory sensitivity in patients with idiopathic scoliosis: Implications for treatment. J. Orthop. Sports Phys. Ther. 1997, 26, 60–68. [Google Scholar] [CrossRef] [Green Version]
- Qiu, Y.; Sun, X.; Qiu, X.; Li, W.; Zhu, Z.; Zhu, F.; Wang, B.; Yu, Y.; Qian, B. Decreased circulating leptin level and its association with body and bone mass in girls with adolescent idiopathic scoliosis. Spine 2007, 32, 2703–2710. [Google Scholar] [CrossRef]
- Burwell, R.G.; Aujla, R.K.; Grevitt, M.P.; Dangerfield, P.H.; Moulton, A.; Randell, T.L.; Anderson, S.I. Pathogenesis of adolescent idiopathic scoliosis in girls—A double neuro-osseous theory involving disharmony between two nervous systems, somatic and autonomic expressed in the spine and trunk: Possible dependency on sympathetic nervous system and hormones with implications for medical therapy. Scoliosis 2009, 4, 24. [Google Scholar]
- Robling, A.G.; Niziolek, P.J.; Baldridge, L.A.; Condon, K.W.; Allen, M.R.; Alam, I.; Mantila, S.M.; Gluhak-Heinrich, J.; Bellido, T.M.; Harris, S.E.; et al. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J. Biol. Chem. 2008, 283, 5866–5875. [Google Scholar] [CrossRef] [Green Version]
- Robinson, J.A.; Chatterjee-Kishore, M.; Yaworsky, P.J.; Cullen, D.M.; Zhao, W.; Li, C.; Kharode, Y.; Sauter, L.; Babij, P.; Brown, E.L.; et al. Wnt/beta-catenin signaling is a normal physiological response to mechanical loading in bone. J. Biol. Chem. 2006, 281, 31720–31728. [Google Scholar] [CrossRef]
- Lin, C.; Jiang, X.; Dai, Z.; Guo, X.; Weng, T.; Wang, J.; Li, Y.; Feng, G.; Gao, X.; He, L. Sclerostin Mediates Bone Response to Mechanical Unloading Through Antagonizing Wnt/b-Catenin Signaling. J. Bone Miner. Res. 2009, 24, 1651–1661. [Google Scholar] [CrossRef] [PubMed]
- Gaudio, A.; Pennisi, P.; Bratengeier, C.; Torrisi, V.; Lindner, B.; Mangiafico, R.A.; Pulvirenti, I.; Hawa, G.; Tringali, G.; Fiore, C.E. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J. Clin. Endocrinol. Metab. 2010, 95, 2248–2253. [Google Scholar] [CrossRef] [Green Version]
- Tian, X.; Jee, W.S.S.; Li, X.; Paszty, C.; Ke, H.Z. Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model. Bone 2011, 48, 197–201. [Google Scholar] [CrossRef] [PubMed]
- Nguyen, J.; Tang, S.Y.; Nguyen, D.; Alliston, T. Load Regulates Bone Formation and SclerostinExpression through a TGFb-Dependent Mechanism. PLoS ONE 2013, 8, e53813. [Google Scholar] [CrossRef] [Green Version]
- Morse, A.; McDonald, M.M.; Kelly, N.H.; Melville, K.M.; Schindeler, A.; Kramer, I.; Kneissel, M.; van der Meulen, M.C.H.; Little, D.G. Mechanical load increases in bone formation via a sclerostin-independent pathway. J. Bone Miner. Res. 2014, 29, 2456–2467. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Vasiliadis, E.S.; Evangelopoulos, D.S.; Kaspiris, A.; Vlachos, C.; Pneumaticos, S.G. Sclerostin and Its Involvement in the Pathogenesis of Idiopathic Scoliosis. J. Clin. Med. 2021, 10, 5286. https://doi.org/10.3390/jcm10225286
Vasiliadis ES, Evangelopoulos DS, Kaspiris A, Vlachos C, Pneumaticos SG. Sclerostin and Its Involvement in the Pathogenesis of Idiopathic Scoliosis. Journal of Clinical Medicine. 2021; 10(22):5286. https://doi.org/10.3390/jcm10225286
Chicago/Turabian StyleVasiliadis, Elias S., Dimitrios Stergios Evangelopoulos, Angelos Kaspiris, Christos Vlachos, and Spyros G. Pneumaticos. 2021. "Sclerostin and Its Involvement in the Pathogenesis of Idiopathic Scoliosis" Journal of Clinical Medicine 10, no. 22: 5286. https://doi.org/10.3390/jcm10225286